|
|
Article: Center for Molecular Medicine Among First Labs in Nation to Offer Groundbreaking Test to Aid in Treatment of Colorectal Cancer.
- Article from:
- PR Newswire
- Article date:
- December 12, 2007
CopyrightCOPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
GRAND RAPIDS, Mich., Dec. 12 /PRNewswire/ -- The Center for Molecular Medicine (CMM) today announced it is one of the first laboratories in the nation to offer a new test to help guide the treatment of metastatic colorectal cancer (CRC; also called stage IV or "advanced").
The CMM (http://www.cmmdx.org/) is offering the CellSearch(TM) System from Veridex (http://www.veridex.com/) to physicians as a vital new tool in managing patients with metastatic CRC.
Recently approved by the FDA for the monitoring of CRC, the CellSearch System identifies and counts circulating tumor cells (CTCs) in a blood sample to predict progression-free and overall-survival in ...